InvestorsHub Logo
Followers 0
Posts 288
Boards Moderated 0
Alias Born 09/25/2005

Re: None

Wednesday, 08/22/2007 12:48:04 PM

Wednesday, August 22, 2007 12:48:04 PM

Post# of 30387
Here's something interesting ... Constab Pharmaceutical (a small Canadian company in Toronto) has developed an "Oncoshuttle" product that sounds like it may be built upon Biocurex's RECAF technology. It uses the receptor for AFP for drug delivery and they have recently concluded a small study of their AIMPILA drug and are now looking for a partner to help take it to clinical trials. They claim the results of the intitial study were promising, but you'll have to judge for yourself.

http://www.constabpharma.com

Their web site also references pictures and data from some of Biocurex's previous studies (Histo-Recaf, I believe), as well as referencing Dr. Moro.

I'm not sure that this company is particularly significant ... they sound like a small company that may have partnered with Biocurex to try delivering their cancer drug via RECAF, but the fact that they have "productized" a drug delivery system that sounds very similar to RECAF is interesting. Not sure what to make of that!
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.